Cost Of Illness Pengobatan Pasien Cronic Kidney Disease dengan Hemodialisa di Instalasi Rawat Jalan RS Soerojo Magelang
Cost of Illness Treatment for Chronic Kidney Disease Patients with Hemodialysis in the Outpatient Installation of Soerojo Hospital, Magelang
DOI:
https://doi.org/10.30872/Keywords:
Analisis Biaya, Biaya Medis, Chronic Kidney DiseaseAbstract
References
[1] M. Nisar et al., “The direct cost of chronic kidney disease (CKD) reported in Asian countries; a systematic literature review,” Cost Effectiveness and Resource Allocation, vol. 22, no. 1, p. 65, Sep. 2024, doi: 10.1186/s12962-024-00566-9.
[2] C. W. G. KDIGO, “KDIGO 2024 Clinical Practice Guideline for the Evaluastion and Management of Chronic Kideney Disease,” Kidney International, vol. 105, no. 4, p. A1, Apr. 2024, doi: 10.1016/S0085-2538(24)00110-8.
[3] N. M. Hustrini, “Chronic Kidney Disease Care in Indonesia: Challenges and Opportunities,” Acta Medica Indonesiana, vol. 55, no. 1, pp. 1–1, Mar. 2023.
[4] S. Sari, Z. Suhada, and T. Triagustini, “Cost of illness pasien gagal ginjal kronis di Rumah Sakit Umum Daerah Arifin Achmad Provinsi Riau,” Jurnal Ilmiah Farmasi, vol. 19, no. 2, pp. 113–125, Dec. 2023, doi: 10.20885/jif.vol19.iss2.art10.
[5] E. Sunariyanti, T. M. Andayani, D. Endarti, and D. A. Puspandari, “Cost Analysis of Chronic Kidney Disease Patients in Indonesia,” Clinicoecon Outcomes Res, vol. 15, pp. 621–629, 2023, doi: 10.2147/CEOR.S388547.
[6] Fauziah, D. Wahyono, and L. E. Budiarti, “Cost Of Illness Dari Chronic Kidney Disease Dengan Tindakan Hemodialisis,” Jurnal Manajemen Dan Pelayanan Farmasi (Journal of Management and Pharmacy Practice), vol. 5, pp. 149–158, 2015.
[7] J. Mende, N. D. Kartikawati, A. Titami, and H. Mahmuda, “Principles Of Dose Adjustment In Patients With Chronic Kidney Failure,” Jurnal Farmasi Sains dan Praktis, pp. 115–126, 2025.
[8] I. Hadning, H. Hendrawan, and W. K. Rahayu, “Cost of illness of chronic kidney disease patients with hemodialysis in Yogyakarta Indonesia,” in AIP Conference Proceedings, AIP Publishing, 2024.
[9] A. R. Villanueva et al., “Cost-of-illness analysis of chronic kidney disease (CKD) management in the Philippines,” Journal of Medical Economics, vol. 28, no. 1, pp. 494–507, Dec. 2025, doi: 10.1080/13696998.2025.2481766.
[10] R. Andhika et al., “One-year Survival of End-Stage Kidney Disease Patients Undergoing Hemodialysis in Indonesia,” Int J Nephrol Renovasc Dis, vol. 18, pp. 87–101, Mar. 2025, doi: 10.2147/IJNRD.S508012.
[11] R. Nindela, S. N. Prastowo, E. F. Zulissetiana, S. Marisdina, and S. S. F. Putri, “Impact of Age Initiation and Duration of Hemodialysis on Impaired Cognitive Function Experienced by Chronic Kidney Disease (CKD) Patients,” Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan, vol. 18, no. 1, pp. 36–43, Jun. 2024, doi: 10.33533/jpm.v18i1.7830.
[12] M. Hecking et al., “Sex-Specific Differences in Mortality and Incident Dialysis in the Chronic Kidney Disease Outcomes and Practice Patterns Study,” Kidney Int Rep, vol. 7, no. 3, pp. 410–423, Dec. 2021, doi: 10.1016/j.ekir.2021.11.018.
[13] N. D. Kartikawati, T. M. Andayani, and D. Endarti, “Gambaran dan Luaran Klinik Terapi Anemia Pada Pasien Chronic Kidney Disease Dengan Hemodialisis Di RS PKU Muhammadiyah Yogyakarta,” Majalah Farmaseutik, vol. 19, no. 1, pp. 148–154, 2023.
[14] S. R. Vaidya and N. R. Aeddula, Chronic Renal Failure. StatPearls Publishing, 2020. Accessed: Mar. 18, 2021. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK535404/
[15] D. T. Zainal, D. G. Tamtomo, and B. Murti, “Correlation between the Characteristics of Chronic Kidney Disease Patients Undergoing Hemodialysis and Erythropoietin Stimulating Agent Therapy and Hemoglobin Levels,” Indonesian Journal of Medicine, vol. 9, no. 2, pp. 145-`155, Apr. 2024, doi: 10.26911/theijmed.2024.9.2.715.
[16] H. N. Murdeshwar and F. Anjum, “Hemodialysis,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2025. Accessed: Sep. 02, 2025. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK563296/
[17] S. Tanaka, T. Nakano, H. Hiyamuta, K. Tsuruya, and T. Kitazono, “Association between Multimorbidity and Kidney Function among Patients with Non-Dialysis-Dependent CKD: The Fukuoka Kidney Disease Registry Study,” J Atheroscler Thromb, vol. 29, no. 8, pp. 1249–1264, Aug. 2022, doi: 10.5551/jat.62900.
[18] C. MacRae, S. W. Mercer, B. Guthrie, and D. Henderson, “Comorbidity in chronic kidney disease: a large cross-sectional study of prevalence in Scottish primary care,” Br J Gen Pract, vol. 71, no. 704, pp. e243–e249, Feb. 2021, doi: 10.3399/bjgp20X714125.
[19] C. Kyriakopoulos and V. Gupta, “Renal Failure Drug Dose Adjustments,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2023. Accessed: Oct. 28, 2023. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK560512/
[20] X. Liu, P. Chen, Y. Liu, X. Jia, and D. Xu, “Medication burden in patients with dialysis-dependent CKD: a systematic review,” Ren Fail, vol. 46, no. 1, p. 2353341, doi: 10.1080/0886022X.2024.2353341.
[21] H. Jyrkilä et al., “Comorbidity and Medication Trends in Chronic Kidney Disease and Incident Atrial Fibrillation: A Nationwide Cohort Study,” Nephron, vol. 148, no. 11–12, pp. 755–767, Jun. 2024, doi: 10.1159/000539603.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Jurnal Sains dan Kesehatan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Deprecated: json_decode(): Passing null to parameter #1 ($json) of type string is deprecated in /home/jskff/public_html/plugins/generic/citations/CitationsPlugin.php on line 68
How to Cite
Similar Articles
- Tunjung Tri Agita, Ekowati Rahajeng, Yeny Sulistyowati, Solikhah, Pengaruh Status Pernikahan terhadap Ketidakpatuhan Minum Obat Antihipertensi di Provinsi Banten: Analisis Data Survei Kesehatan Indonesia 2023 , Jurnal Sains dan Kesehatan: Vol. 7 No. 1 (2026): J. Sains Kes.
- Fuji Fadhilla Sandy, Yasmiwar Susilawati, Zelika Mega Ramadhania, Review: Analisis Kualitatif dan Kuantitatif Kandungan Senyawa Kimia Herba Sasaladaan (Peperomia pellucida (L) H.B.K) , Jurnal Sains dan Kesehatan: Vol. 2 No. 4 (2020): J. Sains Kes.
- Furi Junia Defiq, Fauzia Ningrum Syaputri, Asti Yunia Rindarwati, Analisis Multiatribut Berdasarkan Minat Konsumen Se-Bandung Raya Terhadap Pengembangan Produk Baru Hairtonic (Allium Cepa L.) Sebagai Antiketombe , Jurnal Sains dan Kesehatan: Vol. 3 No. 4 (2021): J. Sains Kes.
- Tri Minarsih, Abdul Roni, Validasi dan Analisis Allopurinol dan Deksamethason pada Jamu Pegal Linudi Kabupaten Semarang dengan KLT dan Spektrofotometri UV-Vis , Jurnal Sains dan Kesehatan: Vol. 5 No. SE-1 (2023): Spesial Edition J. Sains Kes.
- Muhammad Ikhlas Arsul, Nurshalati Tahar, Afrisusnawati Rauf , Analisis Kualitatif dan Kuantitatif Antioksidan Parang Romang , Jurnal Sains dan Kesehatan: Vol. 4 No. 4 (2022): J. Sains Kes.
- Aliya Khadijah Kemaleratu, Yuliana Rahmah Retnaningrum, Yudanti Riastiti, Tingkat Keberhasilan Terapi Radioiodin Pertama pada Pasien Graves’ Disease , Jurnal Sains dan Kesehatan: Vol. 6 No. 1 (2025): J. Sains Kes.
- Meri Utari Susanthy, Rahmat Bakhtiar, Marwan Marwan, Analisis Kontak Pasien TB Terkonfirmasi Bakteriologis di Wilayah Kerja Puskesmas Kecamatan Kongbeng Kabupaten Kutai Timur Tahun 2019 , Jurnal Sains dan Kesehatan: Vol. 3 No. 4 (2021): J. Sains Kes.
- Asrianto Asrianto, Suarna Samai, Muhamad Sahidin, Indra Taufik Sahli, Risda Hartati, Wiwiek Mulyani, Efikasi Biolarvasida Berbagai Tanaman Untuk Pengendalian Vektor Nyamuk Anopheles , Jurnal Sains dan Kesehatan: Vol. 5 No. 2 (2023): J. Sains Kes.
- Annas Rabbani, Arie Ibrahim, Abdillah Iskandar, Hubungan Penggunaan Smartphone dengan Keluhan Tension Type Headache pada Mahasiswa Fakultas Kedokteran Universitas Mulawarman , Jurnal Sains dan Kesehatan: Vol. 3 No. 4 (2021): J. Sains Kes.
- Ira Purbosari, Muhammad Wahyono, Profil Pengetahuan dan Keyakinan Vaksinasi Covid-19 Aztrazeneca dan Sinovac sebagai Upaya Pencegahan Covid-19 pada Warga Surabaya , Jurnal Sains dan Kesehatan: Vol. 4 No. 3 (2022): J. Sains Kes.
You may also start an advanced similarity search for this article.

